53.10
-1.86
(-3.38%)
At close: January 10 at 3:40:06 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
1,822,312.00
1,729,437.00
1,696,350.00
1,948,893.00
1,624,167.00
Cost of Revenue
1,094,266.00
1,087,553.00
1,074,291.00
1,191,022.00
1,034,805.00
Gross Profit
728,046.00
641,884.00
622,059.00
757,871.00
589,362.00
Operating Expense
620,578.00
589,495.00
551,472.00
520,162.00
530,094.00
Operating Income
107,468.00
52,389.00
70,587.00
237,709.00
59,268.00
Net Non Operating Interest Income Expense
-45,290.00
-42,315.00
483.00
-6,392.00
-20,923.00
Pretax Income
133,975.00
66,510.00
151,721.00
541,935.00
325,407.00
Tax Provision
9,627.00
9,703.00
37,242.00
69,751.00
31,872.00
Net Income Common Stockholders
124,347.00
56,807.00
114,474.00
472,185.00
293,552.00
Diluted NI Available to Com Stockholders
124,347.00
56,807.00
114,474.00
472,185.00
293,552.00
Basic EPS
1.62
0.74
1.49
6.16
3.83
Diluted EPS
1.62
0.74
1.49
6.16
3.83
Basic Average Shares
76,028.90
76,633.30
76,633.30
76,633.30
76,633.30
Diluted Average Shares
76,028.90
76,633.30
76,633.30
76,633.30
76,633.30
Rent Expense Supplemental
--
4,156.00
6,011.00
9,561.00
18,321.00
Total Expenses
1,714,844.00
1,677,048.00
1,625,763.00
1,711,184.00
1,564,899.00
Net Income from Continuing & Discontinued Operation
124,347.00
56,807.00
114,474.00
472,185.00
293,552.00
Normalized Income
124,388.77
56,976.70
119,319.30
352,807.28
159,281.63
Interest Income
--
18,574.00
27,569.00
14,024.00
11,059.00
Interest Expense
59,999.00
57,024.00
23,873.00
16,725.00
27,121.00
Net Interest Income
-45,290.00
-42,315.00
483.00
-6,392.00
-20,923.00
EBIT
193,974.00
123,534.00
175,594.00
558,660.00
352,528.00
EBITDA
227,748.00
159,281.00
203,145.00
581,845.00
376,643.00
Reconciled Cost of Revenue
1,094,266.00
1,087,553.00
1,074,291.00
1,191,022.00
1,034,805.00
Reconciled Depreciation
33,774.00
35,747.00
27,551.00
23,185.00
24,115.00
Net Income from Continuing Operation Net Minority Interest
124,347.00
56,807.00
114,474.00
472,185.00
293,552.00
Total Unusual Items Excluding Goodwill
-45.00
-45.00
-5,561.00
137,104.00
148,842.00
Total Unusual Items
91.00
91.00
-5,561.00
137,185.00
148,842.00
Normalized EBITDA
227,657.00
159,190.00
208,706.00
444,660.00
227,801.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-3.23
-11.30
-715.70
17,645.28
14,571.63
3/31/2021 - 12/30/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INDOCO.NS Indoco Remedies Limited
327.80
-1.90%
WINDLAS.NS Windlas Biotech Limited
988.75
-2.69%
THEMISMED.NS Themis Medicare Limited
260.65
-3.91%
RPGLIFE.NS RPG Life Sciences Limited
2,112.25
-4.40%
NEULANDLAB.NS Neuland Laboratories Limited
14,044.55
-4.02%
SHILPAMED.NS Shilpa Medicare Limited
777.15
-3.91%
IPCALAB.NS Ipca Laboratories Limited
1,632.35
-1.78%
GRANULES.NS Granules India Limited
593.60
-2.05%
MOREPENLAB.NS Morepen Laboratories Limited
68.23
-3.75%
LAURUSLABS.NS Laurus Labs Limited
583.70
-4.79%